Array BioPharma Company Profile (NASDAQ:ARRY)

About Array BioPharma

Array BioPharma logoArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer. The Company's wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor for MM; ARRY-797 in Phase II clinical trials, indicated for p38 inhibitor for Lamin A/C-related dilated cardiomyopathy (LMNA-DCM); ARRY-502 in Phase II clinical trials, indicated for CRTh2 antagonist for asthma, and ARRY-614 in Phase I clinical trials, is indicated for p38/Tie2 dual inhibitor for myelodysplastic syndromes (MDS). In addition, the Company has 11 ongoing partner-funded clinical programs, including two MEK inhibitors, which are both in Phase III clinical trials, binimetinib with Novartis and selumetinib with AstraZeneca.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ARRY
  • CUSIP: 04269X10
Key Metrics:
  • Previous Close: $3.44
  • 50 Day Moving Average: $3.68
  • 200 Day Moving Average: $3.27
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.49
  • P/E Growth: -0.48
  • Market Cap: $498.88M
  • Outstanding Shares: 145,022,000
  • Beta: 1.99
Additional Links:
Companies Related to Array BioPharma:

Analyst Ratings

Consensus Ratings for Array BioPharma (NASDAQ:ARRY) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (132.56% upside)

Analysts' Ratings History for Array BioPharma (NASDAQ:ARRY)
Show:
DateFirmActionRatingPrice TargetDetails
8/29/2016Jefferies GroupBoost Price TargetBuy$6.00 -> $7.00View Rating Details
8/9/2016Piper Jaffray Cos.Set Price TargetBuy$7.00View Rating Details
8/5/2016Stifel NicolausBoost Price TargetBuy$7.00 -> $8.00View Rating Details
6/20/2016Leerink SwannReiterated RatingBuyView Rating Details
6/8/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
6/2/2016SunTrust Banks Inc.Initiated CoverageBuy$7.00View Rating Details
1/26/2015JPMorgan Chase & Co.Boost Price TargetOverweight$8.00 -> $9.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Array BioPharma (NASDAQ:ARRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/4/2016Q416($0.14)($0.16)$41.51 million$43.20 millionViewListenView Earnings Details
5/3/2016Q316($0.12)($0.16)$30.35 million$43.00 millionViewListenView Earnings Details
2/2/2016Q216($0.06)($0.17)$32.70 million$35.40 millionViewListenView Earnings Details
11/4/2015Q116($0.18)($0.15)$14.02 million$16.20 millionViewListenView Earnings Details
8/3/2015Q415($0.16)($0.09)$10.29 million$12.30 millionViewListenView Earnings Details
5/4/2015Q315($0.01)$0.37$6.00 million$6.60 millionViewListenView Earnings Details
2/3/2015Q215($0.18)($0.06)$10.20 million$26.92 millionViewListenView Earnings Details
11/4/2014Q115($0.22)($0.21)$6.35 million$6.07 millionViewListenView Earnings Details
8/12/2014Q414($0.23)($0.22)$8.10 million$6.00 millionViewListenView Earnings Details
4/29/2014Q314($0.21)($0.20)$9.40 million$7.80 millionViewListenView Earnings Details
2/4/2014Q214($0.16)($0.13)$13.49 million$14.10 millionViewListenView Earnings Details
10/31/2013Q114($0.18)($0.13)$11.20 million$14.20 millionViewListenView Earnings Details
8/7/2013Q4 2013($0.13)($0.06)$16.13 million$25.40 millionViewListenView Earnings Details
5/6/2013Q3 2013($0.14)($0.19)$14.54 million$10.00 millionViewListenView Earnings Details
2/4/2013Q2 2013($0.14)($0.10)$16.52 million$18.40 millionViewListenView Earnings Details
10/29/2012Q113($0.15)($0.13)$16.70 million$15.80 millionViewN/AView Earnings Details
8/13/2012($0.11)($0.09)ViewN/AView Earnings Details
4/30/2012($0.16)($0.11)ViewN/AView Earnings Details
1/30/2012($0.12)($0.06)ViewN/AView Earnings Details
5/2/2011($0.25)($0.20)ViewN/AView Earnings Details
1/31/2011($0.28)($0.23)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Array BioPharma (NASDAQ:ARRY)
Current Year EPS Consensus Estimate: $-0.68 EPS
Next Year EPS Consensus Estimate: $-0.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.15)($0.16)
Q2 20163($0.18)($0.14)($0.16)
Q4 20163($0.27)$0.09($0.13)
Q1 20172($0.22)($0.21)($0.22)
Q2 20172($0.27)($0.22)($0.25)
Q3 20172($0.26)($0.24)($0.25)
Q4 20172($0.19)($0.05)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Array BioPharma (NASDAQ:ARRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Array BioPharma (NASDAQ:ARRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/20/2016Redmile Group, LlcMajor ShareholderBuy300,000$3.19$957,000.00View SEC Filing  
1/12/2016Redmile Group, LlcMajor ShareholderBuy75,000$3.60$270,000.00View SEC Filing  
1/11/2016Redmile Group, LlcMajor ShareholderBuy925,000$3.67$3,394,750.00View SEC Filing  
10/1/2015Redmile Group, LlcMajor ShareholderBuy782,592$4.58$3,584,271.36View SEC Filing  
8/25/2015Redmile Group, LlcMajor ShareholderBuy790,000$5.38$4,250,200.00View SEC Filing  
8/10/2015Redmile Group, LlcMajor ShareholderBuy1,048,993$5.80$6,084,159.40View SEC Filing  
3/3/2015Kyle LefkoffDirectorSell70,000$8.00$560,000.00View SEC Filing  
3/2/2015Andrews R RobbinsSVPSell21,576$8.25$178,002.00View SEC Filing  
3/2/2015Ron SquarerCEOSell40,000$8.25$330,000.00View SEC Filing  
9/16/2013Liam RatcliffeDirectorSell1,673,172$6.08$10,172,885.76View SEC Filing  
9/6/2013Liam RatcliffeDirectorSell577,286$5.79$3,342,485.94View SEC Filing  
8/2/2013John R MooreVPSell75,384$7.02$529,195.68View SEC Filing  
7/23/2013John R MooreVPSell5,000$6.50$32,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Array BioPharma (NASDAQ:ARRY)
DateHeadline
News IconShares Climbing Higher in Session: Array BioPharma Inc. (NASDAQ:ARRY) - Post News (NASDAQ:ARRY)
www.kentuckypostnews.com - August 29 at 4:10 PM
News IconAnalytical Approach on: Array Biopharma Inc (NASDAQ:ARRY ... - Post Registrar (NASDAQ:ARRY)
postregistrar.com - August 29 at 4:10 PM
thestreet.com logoArray BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies (NASDAQ:ARRY)
www.thestreet.com - August 29 at 4:10 PM
marketnewsvideo.com logoShort Interest Moves 13.5% Lower For ARRY (NASDAQ:ARRY)
www.marketnewsvideo.com - August 25 at 8:58 PM
News IconBiotech news that matter for investors: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Array BioPharma Inc ... - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 25 at 3:37 PM
finance.yahoo.com logoARRAY BIOPHARMA INC Financials (NASDAQ:ARRY)
finance.yahoo.com - August 25 at 3:37 PM
News IconTrading the Biotech News: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 24 at 3:34 PM
News IconBiotech Stocks To Put On Your Watch List: Array BioPharma Inc. (NASDAQ:ARRY), Portola Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 23 at 3:37 PM
capitalcube.com logoETF’s with exposure to Array BioPharma, Inc. : August 23, 2016 (NASDAQ:ARRY)
www.capitalcube.com - August 23 at 3:37 PM
News IconInteresting ARRY Put And Call Options For October 21st (NASDAQ:ARRY)
www.stockoptionschannel.com - August 23 at 7:10 AM
News IconTrading the Biotech News: Array BioPharma Inc. (NASDAQ:ARRY), Sequenom Inc. (NASDAQ:SQNM) - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 22 at 3:38 PM
capitalcube.com logoArray BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016 (NASDAQ:ARRY)
www.capitalcube.com - August 22 at 3:38 PM
prnewswire.com logoArray BioPharma Announces Clinical Data Presentation On ARRY ... - PR Newswire (press release) (NASDAQ:ARRY)
www.prnewswire.com - August 20 at 8:34 AM
News IconHot Biotech Stocks Recap: Array BioPharma Inc. (NASDAQ:ARRY), Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 19 at 4:12 PM
streetinsider.com logoArray Biopharma (ARRY) Reports Data Presentation On ARRY-797 at ESC Congress - StreetInsider.com (NASDAQ:ARRY)
www.streetinsider.com - August 19 at 4:12 PM
publicnow.com logoArray BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress (NASDAQ:ARRY)
www.publicnow.com - August 19 at 4:12 PM
biz.yahoo.com logoARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report (NASDAQ:ARRY)
biz.yahoo.com - August 19 at 11:58 AM
News IconNews review of 2 biotech stocks: Array BioPharma Inc. (NASDAQ:ARRY), Geron Corporation (NASDAQ:GERN) - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 18 at 3:44 PM
News IconHealthcare Stock Buzz: Array BioPharma Inc.'s (ARRY) - Hot Stocks Point (NASDAQ:ARRY)
www.hotstockspoint.com - August 15 at 3:39 PM
capitalcube.com logoETF’s with exposure to Array BioPharma, Inc. : August 11, 2016 (NASDAQ:ARRY)
www.capitalcube.com - August 11 at 12:50 PM
News IconShareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Du... (NASDAQ:ARRY)
ih.advfn.com - August 10 at 3:56 PM
finance.yahoo.com logoShareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential … (NASDAQ:ARRY)
finance.yahoo.com - August 10 at 3:56 PM
finance.yahoo.com logoShareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:ARRY)
finance.yahoo.com - August 10 at 3:56 PM
capitalcube.com logoArray BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016 (NASDAQ:ARRY)
www.capitalcube.com - August 10 at 3:56 PM
capitalcube.com logoArray BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016 (NASDAQ:ARRY)
www.capitalcube.com - August 10 at 9:27 AM
thestreet.com logoArray BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial - TheStreet.com (NASDAQ:ARRY)
www.thestreet.com - August 9 at 10:11 PM
News IconBoulder biotech shares fall Tuesday after disappointing lung cancer trial (NASDAQ:ARRY)
www.9news.com - August 9 at 4:40 PM
baystreet.ca logoArray Biopharma (ARRY) Slides on Tests (NASDAQ:ARRY)
www.baystreet.ca - August 9 at 4:40 PM
thestreet.com logoArray BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial (NASDAQ:ARRY)
www.thestreet.com - August 9 at 4:40 PM
fool.com logoWhy Array BioPharma Inc. Is Plunging Today (NASDAQ:ARRY)
www.fool.com - August 9 at 4:34 PM
marketwatch.com logoArray BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals - MarketWatch (NASDAQ:ARRY)
www.marketwatch.com - August 9 at 12:24 PM
streetupdates.com logoAnalysts Rating Alert: Boston Scientific Corporation (NYSE:BSX) , Array BioPharma Inc. (NASDAQ:ARRY) - Street Updates (NASDAQ:ARRY)
www.streetupdates.com - August 9 at 12:24 PM
thestreet.com logoArray BioPharma (ARRY) Trading With Heavy Volume Before Market Open - TheStreet.com (NASDAQ:ARRY)
www.thestreet.com - August 9 at 12:24 PM
publicnow.com logoAstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer (NASDAQ:ARRY)
www.publicnow.com - August 9 at 12:24 PM
biz.yahoo.com logoARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ARRY)
biz.yahoo.com - August 9 at 12:24 PM
marketwatch.com logoArray BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals (NASDAQ:ARRY)
www.marketwatch.com - August 9 at 12:24 PM
247wallst.com logo3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential (NASDAQ:ARRY)
247wallst.com - August 9 at 12:24 PM
News IconArray Biopharma Inc (NASDAQ:ARRY): That’s How Our Members Are Already up 15% In Just One Week, Alerted At $4 (NASDAQ:ARRY)
www.marketnewscall.com - August 6 at 11:20 AM
News IconHealthcare Stocks in Momentum- Check-Cap (NASDAQ:CHEK ... - Seneca Globe (NASDAQ:ARRY)
www.senecaglobe.com - August 5 at 8:58 PM
equities.com logoArray BioPharma Inc. (ARRY) Jumps 9.27% on August 04 - Equities.com (NASDAQ:ARRY)
www.equities.com - August 5 at 3:36 PM
finance.yahoo.com logoEdited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT (NASDAQ:ARRY)
finance.yahoo.com - August 5 at 3:36 PM
News IconBiotech news that matter for investors: Array BioPharma Inc. (NASDAQ:ARRY), Ariad Pharmaceuticals Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ARRY)
voiceregistrar.com - August 5 at 12:00 PM
News IconArray Biopharma Inc (NASDAQ:ARRY) & Spectra Energy Corp. (NYSE:SE) Stocks to Watch - Money News (press release) (NASDAQ:ARRY)
www.newsismoney.com - August 5 at 12:00 PM
News IconArray BioPharma shares spike following 2Q earnings report (NASDAQ:ARRY)
bizwest.com - August 4 at 9:21 PM
rttnews.com logoEARNINGS SUMMARY: Details of Array BioPharma Inc. Q4 Earnings Report (NASDAQ:ARRY)
www.rttnews.com - August 4 at 9:21 PM
twst.com logoArray BioPharma Inc.: Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 (NASDAQ:ARRY)
www.twst.com - August 4 at 9:21 PM
streetupdates.com logoNotable Analysts Ratings: Envision Healthcare Holdings, Inc. (NYSE:EVHC) , Array BioPharma Inc. (NASDAQ:ARRY) - Street Updates (NASDAQ:ARRY)
www.streetupdates.com - August 4 at 12:05 PM
sg.finance.yahoo.com logoArray BioPharma reports 4Q loss (NASDAQ:ARRY)
sg.finance.yahoo.com - August 4 at 12:05 PM
biz.yahoo.com logoARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:ARRY)
biz.yahoo.com - August 3 at 9:15 PM
streetupdates.com logoAnalysts Reviewing Stocks Update: Pfizer, Inc. (NYSE:PFE) , Array BioPharma Inc. (NASDAQ:ARRY) - Street Updates (NASDAQ:ARRY)
www.streetupdates.com - August 3 at 3:39 PM

Social

Array BioPharma (NASDAQ:ARRY) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff